Cargando…
Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosis
Progressive pulmonary fibrosis is generally diagnosed when interstitial lung disease progression occurs in the absence of any other cause, and a subset of patients with myositis and associated interstitial lung disease may develop progressive pulmonary fibrosis. Numerous autoantibodies (e.g., agains...
Autores principales: | Ceribelli, Angela, Tonutti, Antonio, Isailovic, Natasa, De Santis, Maria, Selmi, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061022/ https://www.ncbi.nlm.nih.gov/pubmed/37007784 http://dx.doi.org/10.3389/fmed.2023.1068402 |
Ejemplares similares
-
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies
por: Ceribelli, Angela, et al.
Publicado: (2020) -
Personalized medicine in rheumatology: the paradigm of serum autoantibodies
por: Sirotti, Silvia, et al.
Publicado: (2017) -
Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023) -
Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis
por: Motta, Francesca, et al.
Publicado: (2023) -
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review
por: Tonutti, Antonio, et al.
Publicado: (2022)